Krevans Sarah 4

What Happened
Sarah Krevans, a director of GRAIL, received an award of 5,491 deferred stock units (DSUs) on 2026-06-18. The units were valued at $63.74 each, for a total grant value of $349,996. This transaction is reported as an award/acquisition (code A) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-18; Form 4 filed: 2026-06-22 (filed within the typical two-business-day reporting window).
• Price used for valuation: $63.74 per share; total value: $349,996.
• Award type: 5,491 DSUs granted in lieu of 5,491 restricted stock units under the 2024 Equity Incentive Plan.
• Vesting: DSUs vest in full on the earlier of (i) June 18, 2027 or (ii) the date of the next annual meeting of stockholders, subject to continued service through the applicable vesting date.
• Each DSU represents the right to receive one share of common stock at settlement.
• Shares owned after the transaction: Not reported on this Form 4.

Context
This is an equity award to a board member (compensation/deferral), not an open-market purchase or sale. DSUs are deferred — they convert to shares at settlement if vesting conditions are met — and do not necessarily indicate immediate buying or selling intent.